Held by
1
portfolio on TandT
Bookmarked by
0
users
Avg position size
7.2%
of holders' portfolios
13F filers
1
institution
Market cap
$47.7B
892M shares
52-week range
$21.11 – $81.42
49% from low
Exchange
NYSE
CS
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconducteurs in France formed STMicroelectronics in 1987. STMicroelectronics is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. It is an especially prominent chip supplier to the industrial and automotive industries.
www.st.com| Trader / Portfolio | Conviction |
|---|---|
| July PortfolioShkreli | Mild7% |
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2024-12-31 | 579,071 | $14.4M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2027-03-16 | $0.0900 | 2027-03-23 |
| 2026-12-15 | $0.0900 | 2026-12-22 |
| 2026-09-22 | $0.0900 | 2026-09-29 |
| 2026-06-23 | $0.0900 | 2026-06-30 |
| 2026-03-24 | $0.0900 | 2026-03-31 |
| 2025-12-16 | $0.0900 | 2025-12-23 |
| 2025-09-23 | $0.0900 | 2025-09-30 |
| 2025-06-24 | $0.0900 | 2025-07-01 |
| 2025-03-25 | $0.0900 | 2025-04-01 |
| 2024-12-17 | $0.0900 | 2024-12-27 |
| 2024-09-24 | $0.0900 | 2024-10-01 |
| 2024-06-25 | $0.0900 | 2024-07-02 |
$STM for the amount of people watching this there is dead silence here… wondering if this is a good pick up at these levels
View on StockTwits ↗$STM STMicroelectronics price target lowered to $60 from $65 at Barclays Barclays analyst Simon Coles lowered the firm's price target on STMicroelectronics to $60 from $65 and keeps an Equal Weight rating on the shares.
View on StockTwits ↗$STM STMicroelectronics price target lowered to $80 from $84 at Mizuho Mizuho lowered the firm's price target on STMicroelectronics to $80 from $84 and keeps an Outperform rating on the shares. The firm recommends buying the post-earnings selloff in the shares, saying STM's bookings remain strong.
View on StockTwits ↗$STM STMicroelectronics price target lowered to $55 from $70 at TD Cowen TD Cowen lowered the firm's price target on STMicroelectronics to $55 from $70 and keeps a Hold rating on the shares. The firm said they posted very solid results, but the stock was not priced for a revenue miss after its year-to-date run. They think the lack of near-term upside and slow path to 40% GM made for a tough post-print reaction.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $14.4B | +22.1% | $1.34 | $1.10–$1.63 | 37.9× | 5 |
| 2027 | $17.0B | +18.1% | $2.64 | $1.87–$3.15 | 19.2× | 6 |
| 2028 | $19.2B | +13.3% | $3.82 | $3.56–$3.98 | 13.3× | 3 |
| 2029 | $20.9B | +9.0% | $4.30 | $4.01–$4.48 | 11.8× | 4 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-23 | $0.26 | $0.31 | +19.2% |
| 2026-04-23 | $0.19 | $0.13 | -31.6% |
| 2026-01-29 | $0.27 | $0.11 | -59.3% |
| 2025-10-23 | $0.22 | $0.29 | +31.8% |
| 2025-07-24 | $0.10 | $0.06 | -40.0% |
| 2025-04-24 | $0.05 | $0.07 | +40.0% |
| 2025-01-30 | $0.35 | $0.37 | +5.7% |
| 2024-10-31 | $0.33 |
| $0.37 |
| +12.1% |
| $29.2B |
| — |
| JBLJabil Inc. | $311.29 | -0.42% | $32.6B | — |
| ONON Semiconductor Corporation | $89.04 | +2.57% | $34.7B | — |
Source: Financial Modeling Prep · peers by sector/industry
MRNA
Moderna, Inc. Common Stock
1 co-holder · 100% overlap
ADBE
Adobe Inc.
1 co-holder · 100% overlap
BCRX
BioCryst Pharmaceuticals Inc
1 co-holder · 100% overlap
MU
Micron Technology, Inc.
1 co-holder · 100% overlap
SNPS
Synopsys Inc
1 co-holder · 100% overlap
SPRB
Spruce Biosciences, Inc. Common Stock
1 co-holder · 100% overlap
LITE
Lumentum Holdings Inc. Common Stock
1 co-holder · 100% overlap
SRPT
Sarepta Therapeutics,, Inc. Common Stock
1 co-holder · 100% overlap
Ranked by collective conviction (sum of co-holders' % allocation) across public portfolios holding STM.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.